-
1
-
-
33646360865
-
Clinical practice. Thrombotic thrombocytopenic purpura
-
George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006;354:1927-35.
-
(2006)
N Engl J Med.
, vol.354
, pp. 1927-1935
-
-
George, J.N.1
-
2
-
-
0032569884
-
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome
-
Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. N Engl J Med. 1998;339:1578-84.
-
(1998)
N Engl J Med.
, vol.339
, pp. 1578-1584
-
-
Furlan, M.1
Robles, R.2
Galbusera, M.3
Remuzzi, G.4
Kyrle, P.A.5
Brenner, B.6
-
3
-
-
57749170320
-
TTP and ADAMTS-13. When is testing appropriate?
-
Pier MM, Flora P. TTP and ADAMTS-13. When is testing appropriate? Hematology. 2007;2007:121-6.
-
(2007)
Hematology.
, vol.2007
, pp. 121-126
-
-
Pier, M.M.1
Flora, P.2
-
4
-
-
78549253211
-
How I treat patients with thrombotic thrombocytopenic purpura: 2010
-
George JN. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood. 2010;116:4060-9.
-
(2010)
Blood.
, vol.116
, pp. 4060-4069
-
-
George, J.N.1
-
5
-
-
33644795851
-
Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura
-
Coppo P, Wolf M, Veyradier A, Bussel A, Malot S, Millot GA, et al. Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura. Br J Haematol. 2006;132:66-74.
-
(2006)
Br J Haematol.
, vol.132
, pp. 66-74
-
-
Coppo, P.1
Wolf, M.2
Veyradier, A.3
Bussel, A.4
Malot, S.5
Millot, G.A.6
-
6
-
-
33846018020
-
Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13
-
Scully M, Cohen H, Cavenagh J, Benjamin S, Starke R, Killick S, et al. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. Br J Haematol. 2007;136:451-61.
-
(2007)
Br J Haematol.
, vol.136
, pp. 451-461
-
-
Scully, M.1
Cohen, H.2
Cavenagh, J.3
Benjamin, S.4
Starke, R.5
Killick, S.6
-
7
-
-
84055166960
-
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with suboptimal response to plasma exchange
-
Froissart A, Buffet M, Veyradier A, Poullin Provot F, Malot S, Shwarzinger M, et al. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with suboptimal response to plasma exchange. Crit Care Med. 2012;40:104-11.
-
(2012)
Crit Care Med.
, vol.40
, pp. 104-111
-
-
Froissart, A.1
Buffet, M.2
Veyradier, A.3
Poullin Provot, F.4
Malot, S.5
Shwarzinger, M.6
-
8
-
-
80051866867
-
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura
-
Scully M, McDonald V, Cavenagh J, Hunt BJ, Longair I, Cohen H, et al. A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura. Blood. 2011;118:1746-53.
-
(2011)
Blood.
, vol.118
, pp. 1746-1753
-
-
Scully, M.1
McDonald, V.2
Cavenagh, J.3
Hunt, B.J.4
Longair, I.5
Cohen, H.6
-
9
-
-
0037968640
-
ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients
-
Vesely SK, George JN, Lammle B, Studt JD, Alberio L, El-Harake MA, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003;102:60-8.
-
(2003)
Blood.
, vol.102
, pp. 60-68
-
-
Vesely, S.K.1
George, J.N.2
Lammle, B.3
Studt, J.D.4
Alberio, L.5
El-Harake, M.A.6
-
10
-
-
47249144803
-
VonWillebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura
-
Sadler JE. VonWillebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood. 2008;112:11-8.
-
(2008)
Blood.
, vol.112
, pp. 11-18
-
-
Sadler, J.E.1
-
11
-
-
77649205284
-
Successful long-term rituximab maintenance for a relapsing patient with idiopathic thrombotic thrombocytopenic purpura
-
Ojeda-Uribe M, Federici L, Wolf M, Coppo P, Veyradier A. Successful long-term rituximab maintenance for a relapsing patient with idiopathic thrombotic thrombocytopenic purpura. Transfusion. 2010;50:733-5.
-
(2010)
Transfusion.
, vol.50
, pp. 733-735
-
-
Ojeda-Uribe, M.1
Federici, L.2
Wolf, M.3
Coppo, P.4
Veyradier, A.5
-
12
-
-
77954397953
-
Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome
-
Caramazza D, Quintini G, Abbene I, Coco LL, Malato A, Di Trapani R, et al. Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome. Blood Transfus. 2010; 8:203-10.
-
(2010)
Blood Transfus.
, vol.8
, pp. 203-210
-
-
Caramazza, D.1
Quintini, G.2
Abbene, I.3
Coco, L.L.4
Malato, A.5
Di Trapani, R.6
-
13
-
-
84868129528
-
Short-and long-term effects of rituximab for the treatment of thrombotic thrombocytopenic pupura: Four case reports
-
Iioka F, Shimomura D, Ishii T, Maesako Y, Ohgoe K, Nakamura F, et al. Short-and long-term effects of rituximab for the treatment of thrombotic thrombocytopenic pupura: four case reports. Int J Hematol. 2012;96:506-12.
-
(2012)
Int J Hematol.
, vol.96
, pp. 506-512
-
-
Iioka, F.1
Shimomura, D.2
Ishii, T.3
Maesako, Y.4
Ohgoe, K.5
Nakamura, F.6
-
14
-
-
44949126978
-
Lower dose rituximab is active in adult patients with idiopathic thrombocytopenic purpura
-
Zaja F, Battista ML, Pirrotta MT, Palmieri S, Montagna M, Vianelli N, et al. Lower dose rituximab is active in adult patients with idiopathic thrombocytopenic purpura. Haematologica. 2008;93:930-3.
-
(2008)
Haematologica.
, vol.93
, pp. 930-933
-
-
Zaja, F.1
Battista, M.L.2
Pirrotta, M.T.3
Palmieri, S.4
Montagna, M.5
Vianelli, N.6
-
15
-
-
78649690155
-
Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias
-
Gomez-Almaguer D, Solano-Genesta M, Tarin-Arzaga L, Herrera Garza JL, Cantu-Rodriguez OG, Gutierrez-Aguirre CH, et al. Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias. Blood. 2010;116:4783-5.
-
(2010)
Blood.
, vol.116
, pp. 4783-4785
-
-
Gomez-Almaguer, D.1
Solano-Genesta, M.2
Tarin-Arzaga, L.3
Herrera Garza, J.L.4
Cantu-Rodriguez, O.G.5
Gutierrez-Aguirre, C.H.6
-
16
-
-
78751580375
-
Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia
-
Li Z, Mou W, Lu G, Cao J, He X, Pan X, et al. Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia. Int J Hematol. 2011;93:91-8.
-
(2011)
Int J Hematol.
, vol.93
, pp. 91-98
-
-
Li, Z.1
Mou, W.2
Lu, G.3
Cao, J.4
He, X.5
Pan, X.6
-
17
-
-
84860350202
-
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: Clinical efficacy and biologic studies
-
Barcellini W, Zaja F, Zaninoni A, Imperiali FG, Battista ML, Di Bona E, et al. Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies. Blood. 2012;119:3691-7.
-
(2012)
Blood.
, vol.119
, pp. 3691-3697
-
-
Barcellini, W.1
Zaja, F.2
Zaninoni, A.3
Imperiali, F.G.4
Battista, M.L.5
Di Bona, E.6
-
18
-
-
79955044153
-
Human immunodeficiency virus associated thrombotic thrombocytopenic purpura-favourable outcome with plasma exchange and prompt initiation of highly active antiretroviral therapy
-
Hart D, Sayer R, Miller R, Edwards S, Kelly A, Baglin T, et al. Human immunodeficiency virus associated thrombotic thrombocytopenic purpura-favourable outcome with plasma exchange and prompt initiation of highly active antiretroviral therapy. Br J Haematol. 2011;153:515-9.
-
(2011)
Br J Haematol.
, vol.153
, pp. 515-519
-
-
Hart, D.1
Sayer, R.2
Miller, R.3
Edwards, S.4
Kelly, A.5
Baglin, T.6
|